Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for BioXcel Therapeutics Inc have a median target of 6.00, with a high estimate of 18.00 and a low estimate of 1.00. The median estimate represents a 802.26% increase from the last price of 0.665.
High | 2,606.8% | 18.00 |
Med | 802.3% | 6.00 |
Low | 50.4% | 1.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 14, 2024.
Average growth rate | +30.80% |
Average growth rate | -36.14% |
More ▼
Revenue history & estimates in USD
Average growth rate | +32.34% |
Average growth rate | +89.33% |
More ▼